Compare YieldMax NVDA Option Income Strategy ETF (NVDY) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
YieldMax NVDA Option Income Strategy ETF vs Tenet Healthcare Corporation — how do they compare? YieldMax NVDA Option Income Strategy ETF trades at $12.78 (market cap $1.46B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Tenet Healthcare Corporation is far larger — about 14.3× YieldMax NVDA Option Income Strategy ETF's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, YieldMax NVDA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold YieldMax NVDA Option Income Strategy ETF for 43 Days and Tenet Healthcare Corporation for 15 Days on average.
| NVDY | THC | |
|---|---|---|
Market Cap | $1.46B | $20.92B |
Volume | 1,111,033 | 455,764 |
Sector | Income / Options Overlay | Health |
52-Week High | $17.21 | $280.77 |
52-Week Low | $11.58 | $161.37 |
Typical Hold Time | 43 Days | 15 Days |
Enterprise Value | — | $32.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVDY trades at $13.01, down 0.31% on the day, with a bullish technical signal from moving averages but neutral oscillators. The ETF generates weekly dividends, averaging around $0.10 per share recently, reflecting its income-focused strategy tied to NVIDIA's stock volatility. However, key valuation ratios like P/E and P/S are unavailable, limiting fundamental clarity.
The outlook is mixed: strong dividend yields appeal to income seekers, but structural caps on upside participation and potential NAV erosion pose long-term risks. Analyst sentiment has shifted to hold due to declining volatility in NVIDIA, suggesting cautious optimism for income but limited growth potential.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About YieldMax NVDA Option Income Strategy ETF
NVDY is an actively managed ETF that pursues a synthetic covered call strategy on NVIDIA Corporation (NVDA) stock. The fund primarily sells call options on NVDA and invests in U.S. Treasury securities and other high-quality collateral. Its goal is to generate monthly income from the option premiums. This strategy provides exposure to the high-growth potential of NVDA while seeking to deliver a high yield, though it caps the potential capital appreciation of the stock.
Read more on NVDY →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
